Dorsomedial striatal neuroinflammation causes excessive goal-directed action control by disrupting astrocyte function.
Saved in:
| Title: | Dorsomedial striatal neuroinflammation causes excessive goal-directed action control by disrupting astrocyte function. |
|---|---|
| Authors: | Abiero AR; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia.; Centre for Neuroscience and Regenerative Medicine, St. Vincent's Centre for Applied Medical Research, St. Vincent's Health Network, Sydney, NSW, Australia.; School of Psychology, Faculty of Science, University of Sydney, Sydney, NSW, Australia., Gladding JM; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia., Iredale JA; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia.; Brain Neuromodulation Research Program, Hunter Medical Research Institute, New Lambton Heights, Sydney, NSW, Australia., Drury HR; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia.; Brain Neuromodulation Research Program, Hunter Medical Research Institute, New Lambton Heights, Sydney, NSW, Australia., Manning EE; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia.; Brain Neuromodulation Research Program, Hunter Medical Research Institute, New Lambton Heights, Sydney, NSW, Australia., Dayas CV; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia.; Brain Neuromodulation Research Program, Hunter Medical Research Institute, New Lambton Heights, Sydney, NSW, Australia., Dhungana A; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia.; Centre for Neuroscience and Regenerative Medicine, St. Vincent's Centre for Applied Medical Research, St. Vincent's Health Network, Sydney, NSW, Australia., Ganesan K; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia.; Centre for Neuroscience and Regenerative Medicine, St. Vincent's Centre for Applied Medical Research, St. Vincent's Health Network, Sydney, NSW, Australia.; School of Psychology, Faculty of Science, University of Sydney, Sydney, NSW, Australia., Turner K; School of Psychology, University of New South Wales, Sydney, NSW, Australia., Becchi S; Decision Neuroscience Laboratory, School of Psychology, University of New South Wales, Sydney, NSW, Australia.; Teva Pharmaceuticals, Sydney, NSW, Australia., Kendig MD; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia., Nolan C; Decision Neuroscience Laboratory, School of Psychology, University of New South Wales, Sydney, NSW, Australia., Balleine B; Decision Neuroscience Laboratory, School of Psychology, University of New South Wales, Sydney, NSW, Australia., Castorina A; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia., Cole L; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia., Clemens KJ; School of Psychology, University of New South Wales, Sydney, NSW, Australia., Bradfield LA; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia. laura.bradfield@sydney.edu.au.; Centre for Neuroscience and Regenerative Medicine, St. Vincent's Centre for Applied Medical Research, St. Vincent's Health Network, Sydney, NSW, Australia. laura.bradfield@sydney.edu.au.; School of Psychology, Faculty of Science, University of Sydney, Sydney, NSW, Australia. laura.bradfield@sydney.edu.au. |
| Source: | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2026 Jan; Vol. 51 (2), pp. 486-496. Date of Electronic Publication: 2025 Sep 27. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8904907 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1740-634X (Electronic) Linking ISSN: 0893133X NLM ISO Abbreviation: Neuropsychopharmacology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
